Characteristics | Total (%) | Patients with adverse drug effects (%) | ||
---|---|---|---|---|
 |  | 0 ADR → 1 st ADR | 1 st ADR → 2 nd ADR | 2 st ADR → 3 nd ADR |
Overall | 590 (100) | 217 (100) | 61 (100) | 24 (100) |
Gender | Â | Â | Â | Â |
Male | 192 (33) | 61 (28) | 16 (26) | 5 (21) |
Female | 398 (67) | 156 (72) | 45 (74) | 19 (79) |
Age at clinic visit | Â | Â | Â | Â |
30 and less | 87 (15) | 22 (10) | 2 (3) | 0 (0) |
31 – 37 | 183 (31) | 64 (29) | 14 (23) | 5 (21) |
38 – 44 | 154 (26) | 70 (32) | 24 (39) | 10 (42) |
45+ | 166 (28) | 61 (28) | 21 (34) | 9 (37) |
Clinic | Â | Â | Â | Â |
Clinic A | 188 (32) | 32 (15) | 5 (8) | 1(4) |
Clinic B | 31 (5) | 4 (2) | 0 (0) | 0 (0) |
Clinic C | 318 (54) | 162 (75) | 48 (79) | 19 (79) |
Clinic D | 53 (9) | 19 (9) | 8 (13) | 4 (17) |
ART regimens | Â | Â | Â | Â |
1a (d4T, 3TC, EFZ)* | 402 (68) | 144 (66) | 38 (62) | 12 (50) |
1b (d4T, 3TC, NVP)* | 67 (11) | 20 (9) | 3 (5) | 1(4) |
1c (AZT, 3TC, EFZ)* | 46 (8) | 25 (12) | 12 (20) | 4 (17) |
Others | 75 (13) | 28 (13) | 8 (13) | 7 (29) |
Year started ART | Â | Â | Â | Â |
Before 2009 | 194 (33) | 94 (43) | 40 (66) | 21 (88) |
2009 and after | 396 (67) | 123 (57) | 21 (34) | 3 (13) |